These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16854457)

  • 1. Oral contraceptives and neuroactive steroids.
    Rapkin AJ; Biggio G; Concas A
    Pharmacol Biochem Behav; 2006 Aug; 84(4):628-34. PubMed ID: 16854457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased neuroactive steroids induced by combined oral contraceptive pills are not associated with mood changes.
    Rapkin AJ; Morgan M; Sogliano C; Biggio G; Concas A
    Fertil Steril; 2006 May; 85(5):1371-8. PubMed ID: 16580672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroactive steroids and affective disorders.
    Eser D; Schüle C; Baghai TC; Romeo E; Uzunov DP; Rupprecht R
    Pharmacol Biochem Behav; 2006 Aug; 84(4):656-66. PubMed ID: 16831459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroactive steroids as modulators of depression and anxiety.
    Eser D; Romeo E; Baghai TC; di Michele F; Schüle C; Pasini A; Zwanzger P; Padberg F; Rupprecht R
    Neuroscience; 2006; 138(3):1041-8. PubMed ID: 16310959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons.
    Bäckström T; Haage D; Löfgren M; Johansson IM; Strömberg J; Nyberg S; Andréen L; Ossewaarde L; van Wingen GA; Turkmen S; Bengtsson SK
    Neuroscience; 2011 Sep; 191():46-54. PubMed ID: 21600269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurosteroids and neuroactive drugs in mental disorders.
    Pisu MG; Serra M
    Life Sci; 2004 May; 74(26):3181-97. PubMed ID: 15094320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroactive steroids in depression and anxiety disorders: clinical studies.
    Eser D; Schüle C; Baghai TC; Romeo E; Rupprecht R
    Neuroendocrinology; 2006; 84(4):244-54. PubMed ID: 17159334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of scales for evaluating premenstrual symptoms in women using oral contraceptives.
    Coffee AL; Kuehl TJ; Sulak PJ
    Pharmacotherapy; 2008 May; 28(5):576-83. PubMed ID: 18447656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroactive steroid regulation of neurotransmitter release in the CNS: action, mechanism and possible significance.
    Zheng P
    Prog Neurobiol; 2009 Oct; 89(2):134-52. PubMed ID: 19595736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse mood effects of combined oral contraceptives in relation to personality traits.
    Borgström A; Odlind V; Ekselius L; Sundström-Poromaa I
    Eur J Obstet Gynecol Reprod Biol; 2008 Dec; 141(2):127-30. PubMed ID: 18760521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of psychiatric disorders and premenstrual dysphoric symptoms in patients with experience of adverse mood during treatment with combined oral contraceptives.
    Segebladh B; Borgström A; Odlind V; Bixo M; Sundström-Poromaa I
    Contraception; 2009 Jan; 79(1):50-5. PubMed ID: 19041441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptives and mood in women with and without premenstrual dysphoria: a theoretical model.
    Kurshan N; Neill Epperson C
    Arch Womens Ment Health; 2006 Jan; 9(1):1-14. PubMed ID: 16206030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroactive steroids: focus on human brain.
    Melcangi RC; Panzica G; Garcia-Segura LM
    Neuroscience; 2011 Sep; 191():1-5. PubMed ID: 21704130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential clinical uses of neuroactive steroids.
    Zorumski CF; Mennerick S; Isenberg KE; Covey DF
    IDrugs; 2000 Sep; 3(9):1053-63. PubMed ID: 16049865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plastic neuronal changes in GABA(A) receptor gene expression induced by progesterone metabolites: in vitro molecular and functional studies.
    Biggio F; Gorini G; Caria S; Murru L; Mostallino MC; Sanna E; Follesa P
    Pharmacol Biochem Behav; 2006 Aug; 84(4):545-54. PubMed ID: 16914187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential clinical uses of neuroactive steroids.
    Zorumski CF; Mennerick S; Isenberg KE; Covey DF
    Curr Opin Investig Drugs; 2000 Nov; 1(3):360-9. PubMed ID: 11249720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurosteroids, neuroactive steroids, and symptoms of affective disorders.
    Dubrovsky B
    Pharmacol Biochem Behav; 2006 Aug; 84(4):644-55. PubMed ID: 16962651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroactive steroids in responders and nonresponders to sleep deprivation.
    Schüle C; Di Michele F; Baghai T; Romeo E; Bernardi G; Zwanzger P; Padberg F; Pasini A; Rupprecht R
    Ann N Y Acad Sci; 2004 Dec; 1032():216-23. PubMed ID: 15677414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of neuroactive steroids and GABA in the development of neuropsychiatric disorders in women.
    Amin Z; Mason GF; Cavus I; Krystal JH; Rothman DL; Epperson CN
    Pharmacol Biochem Behav; 2006 Aug; 84(4):635-43. PubMed ID: 16860856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.